https://www.selleckchem.com/pr....oducts/Rapamycin.htm
004). Among the 24 patients discharged on quinidine, 13 (54.2%) had VA recurrence during a median of 138days. Adverse effects in 9 of the 37 patients (24.3%) led to drug discontinuation, most commonly gastrointestinal intolerance. In patients with recurrent VAs and structural heart disease who have limited treatment options,quinidine can be useful, particularly as a short-term therapy. In patients with recurrent VAs and structural heart disease who have limited treatment options, quinidine can be useful, particularly as a short-term t
Like
Comment
Share
